Trial Information

Summary: AdvanceMed Research is recruiting male and female volunteers to participate in a clinical research study evaluating the safety and effectiveness of an investigational medication for the treatment of Overactive Bladder.

Participation in this study involves five visits over a period of approximately 12 weeks.

Symptoms of Overactive Bladder include:

  • frequent urination
  • Strong sudden desires to urinate that are hard to control (urinary urgency)
  • Accidental leakage of urine due to urgency to urinate

If you are experiencing any of these symptoms, you may be interested in learning more about this clinical research study.

Qualified participants will receive study-related exams, lab tests and study medication, all at no charge.

For an Initial prescreening evaluation, contact:

Contact:

Melissa Ciatteo, Clinical Research Coordinator
AdvanceMed Research
3120 Princeton Pike
Lawrenceville, NJ 08648
Telephone: 609-895-1991
Fax: 609-895-0173
Email:

Profile Page: AdvanceMed Research, Lawrenceville, NJ

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:37 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA